DuChemBIO Co.,Ltd. (KOSDAQ:176750)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Manufacturing and Sales of Radiopharmaceuticals and Related Medical Devices	38.57B	35.60B	34.70B
Manufacturing and Sales of Radiopharmaceuticals and Related Medical Devices Growth	8.35%	2.61%	-
Total	38.57B	35.60B	34.70B
Total Growth	8.35%	2.61%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
South Korea	38.46B	35.56B	34.59B
South Korea Growth	8.17%	2.79%	-
North America	18.02M	5.37M	59.79M
North America Growth	235.47%	-91.02%	-
Oceania	58.83M	22.05M	13.28M
Oceania Growth	166.86%	65.96%	-
Asia	35.68M	18.09M	30.72M
Asia Growth	97.23%	-41.11%	-
Total	38.57B	35.60B	34.70B
Total Growth	8.35%	2.61%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error